IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
ASX:IDT
Price:
0.091 AUD
-4.21%
Market Closed
Updated:
May 3, 2024
IDT Australia Ltd
Cash from Operating Activities
|
IDT Australia Ltd
Cash from Operating Activities Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDT Australia Ltd
ASX:IDT
|
Cash from Operating Activities
-AU$7.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-92%
|
CAGR 10-Years
-22%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Operating Activities
-AU$42.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Operating Activities
AU$184.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Operating Activities
-AU$10.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-29%
|
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Operating Activities
AU$15.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Operating Activities
-AU$27.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's Cash from Operating Activities?
Cash from Operating Activities
-7.9m
AUD
-7.9m
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Cash from Operating Activities amounts to -7.9m AUD.
What is IDT Australia Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-22%
-22%
Over the last year, the Cash from Operating Activities growth was -4%.
You don't have any saved screeners yet
